Literature DB >> 22399555

Sarcopenia in the elderly.

John E Morley1.   

Abstract

Sarcopenia is the age-related loss of muscle. It leads to loss of muscle power, which in the end results in frailty and disability. There are numerous causes of sarcopenia. Treatment consists of resistance exercise and a leucine-enriched essential amino acid protein supplement. There is an emerging role for testosterone and other anabolic steroids. An activin II receptor soluble fusion protein is showing great potential to increase muscle mass and bone mineral density.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22399555     DOI: 10.1093/fampra/cmr063

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  61 in total

1.  Analysis of effects of loading and postural demands on upper limb reaching in older adults using statistical parametric mapping.

Authors:  Xiaotong Li; Anthony C Santago; Meghan E Vidt; Katherine R Saul
Journal:  J Biomech       Date:  2016-06-23       Impact factor: 2.712

2.  Short-term strength training improves muscle quality and functional capacity of elderly women.

Authors:  Ronei Silveira Pinto; Cleiton Silva Correa; Regis Radaelli; Eduardo Lusa Cadore; Lee E Brown; Martim Bottaro
Journal:  Age (Dordr)       Date:  2013-07-24

3.  Impact of whole-body electromyostimulation on body composition in elderly women at risk for sarcopenia: the Training and ElectroStimulation Trial (TEST-III).

Authors:  Wolfgang Kemmler; Michael Bebenek; Klaus Engelke; Simon von Stengel
Journal:  Age (Dordr)       Date:  2013-08-16

4.  Sarcopenia assessment project in the nursing homes in Turkey.

Authors:  M Halil; Z Ulger; M Varlı; A Döventaş; G B Oztürk; M E Kuyumcu; B B Yavuz; Y Yesil; F Tufan; M Cankurtaran; B Saka; S Sahin; A Curgunlu; N Tekin; F Akçiçek; M A Karan; T Atlı; T Beger; D S Erdinçler; S Arıoğul
Journal:  Eur J Clin Nutr       Date:  2014-02-26       Impact factor: 4.016

5.  Effect of Protein Supplementation Combined with Resistance Training on Muscle Mass, Strength and Function in the Elderly: A Systematic Review and Meta-Analysis.

Authors:  L Hou; Y Lei; X Li; C Huo; X Jia; J Yang; R Xu; X Wang
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

6.  Editorial: Frailty, Comorbidity, and COPD.

Authors:  E Charbek; J R Espiritu; R Nayak; J E Morley
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

7.  Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults.

Authors:  D Scott; A Hayes; K M Sanders; D Aitken; P R Ebeling; G Jones
Journal:  Osteoporos Int       Date:  2013-06-26       Impact factor: 4.507

8.  Sarcopenia and the New ICD-10-CM Code: Screening, Staging, and Diagnosis Considerations.

Authors:  Laura J Falcon; Michael O Harris-Love
Journal:  Fed Pract       Date:  2017-07-09

9.  Promoting access to innovation for frail old persons. IAGG (International Association of Gerontology and Geriatrics), WHO (World Health Organization) and SFGG (Société Française de Gériatrie et de Gérontologie) Workshop--Athens January 20-21, 2012.

Authors:  G Berrut; S Andrieu; I Araujo de Carvalho; J P Baeyens; H Bergman; B Cassim; F Cerreta; M Cesari; H B Cha; L K Chen; A Cherubini; M Y Chou; A J Cruz-Jentoft; L De Decker; P Du; B Forette; F Forette; A Franco; R Guimaraes; L M Guttierrez-Robledo; J Jauregui; V Khavinson; W J Lee; L N Peng; C Perret-Guillaume; M Petrovic; F Retornaz; K Rockwood; L Rodriguez-Manas; C Sieber; G Spatharakis; O Theou; E Topinkova; B Vellas; A Benetos
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

10.  An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy.

Authors:  Estelle Lach-Trifilieff; Giulia C Minetti; KellyAnn Sheppard; Chikwendu Ibebunjo; Jerome N Feige; Steffen Hartmann; Sophie Brachat; Helene Rivet; Claudia Koelbing; Frederic Morvan; Shinji Hatakeyama; David J Glass
Journal:  Mol Cell Biol       Date:  2013-12-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.